Arkolith/Insider Trading/SPRY/Form 4

Flynn James E

10% OwnerARS Pharmaceuticals, Inc. (SPRY) · full profile →Form 4 · filed Jul 1, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13.7M
Net Open-Market Flow
-$13.7M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2025Sell(S)370K$18.46$6.8M4.9M
Jun 27, 2025Sell(S)370K$18.46$6.8M4.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-25-000959) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML